{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:59:07Z","timestamp":1789469947194,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.hlc.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T17:23:34Z","timestamp":1646846614000},"page":"964-973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Subjective and Objective Impact of Angiotensin Receptor\u2013Neprilysin Inhibitors on Systemic Right Ventricle Patients"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3995-1140","authenticated-orcid":false,"given":"Georges","family":"Ephrem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"McCollum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Green-Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya E.","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa A.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2022.02.005_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2010.03.085","article-title":"Changing mortality in congenital heart disease","volume":"56","author":"Khairy","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.hlc.2022.02.005_bib2","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","article-title":"Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium","volume":"122","author":"Moons","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2022.02.005_bib3","first-page":"46","article-title":"Congenital heart disease: an ageing problem","volume":"25","author":"Norrish","year":"2018","journal-title":"Br J Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2022.02.005_bib4","first-page":"705","article-title":"Adult congenital heart disease: past, present, and future","volume":"38","author":"Moodie","year":"2011","journal-title":"Tex Heart Inst J"},{"issue":"16","key":"10.1016\/j.hlc.2022.02.005_bib5","first-page":"1233","article-title":"Risk factors for excess mortality in adults with congenital heart diseases","volume":"38","author":"Oliver","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2022.02.005_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2016.02.133","article-title":"Cause of death in adults with congenital heart disease - an analysis of the German National Register for Congenital Heart Defects","volume":"211","author":"Engelings","year":"2016","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.hlc.2022.02.005_bib7","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hlc.2022.02.005_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/hrt.2009.185595","article-title":"The emerging burden of hospital admissions of adults with congenital heart disease","volume":"96","author":"Verheugt","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2022.02.005_bib9","doi-asserted-by":"crossref","unstructured":"Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et\u00a0al., Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am. J. Cardiol. 97(2006):1238\u201343.","DOI":"10.1016\/j.amjcard.2005.10.065"},{"key":"10.1016\/j.hlc.2022.02.005_bib10","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.02.005_bib11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2022.02.005_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/eurheartj\/ehv741","article-title":"Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology","volume":"37","author":"Budts","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.hlc.2022.02.005_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2022.02.005_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","article-title":"Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)","volume":"193","author":"Shaddy","year":"2017","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.hlc.2022.02.005_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.hlc.2018.12.003","article-title":"Sacubitril\/valsartan in adult congenital heart disease patients with chronic heart failure \u2212 a single centre case series and call for an international registry","volume":"29","author":"Appadurai","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"3","key":"10.1016\/j.hlc.2022.02.005_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"10.1016\/j.hlc.2022.02.005_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.031","article-title":"Sacubitril\/valsartan for heart failure in adults with complex congenital heart disease","volume":"300","author":"Maurer","year":"2020","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2022.02.005_bib18","first-page":"108","article-title":"Ejection fraction improvement and reverse remodeling achieved with sacubitril\/valsartan in heart failure with reduced ejection fraction patients","volume":"7","author":"Almufleh","year":"2017","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.hlc.2022.02.005_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hlc.2022.02.005_bib20","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.hlc.2022.02.005_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.hlc.2022.02.005_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2005-916153","article-title":"Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension","volume":"26","author":"Hargett","year":"2005","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:06:05Z","timestamp":1761415565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1443950622000567"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2022.02.005","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subjective and Objective Impact of Angiotensin Receptor\u2013Neprilysin Inhibitors on Systemic Right Ventricle Patients","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}